http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Valentin N. Sapunov,Antonina A. Stepacheva,Esther M. Sulman,Johan Wärnåc,Päivi Mäki-Arvela,Mikhail G. Sulman,Alexander I. Sidorov,Barry D. Stein,Dmitry Yu. Murzin,Valentina G. Matveeva 한국공업화학회 2017 Journal of Industrial and Engineering Chemistry Vol.46 No.-
Stearic acid hydrodeoxygenation into n-heptadecane on the catalyst containing Pd nanoparticlesincorporated in the hypercrosslinked polystyrene matrix was studied. The used catalysts werecharacterized using TEM, CO chemisorption, low-temperature nitrogen physisorption and XPS. A clearhydrogen pressure dependent induction period was noticed. Kinetic regularities were studied for theindicated reaction in the presence of polymer based catalysts. A mathematical model for decarboxylationwas suggested which was able to adequately describe experimental data at different temperatures,hydrogen pressures and initial concentrations of stearic acid. Kinetic constants were calculated and theirstatistical analysis was performed.
Awan, Tashfeen,Iqbal, Zafar,Aleem, Aamer,Sabir, Noreen,Absar, Muhammad,Rasool, Mahmood,Tahir, Ammara H.,Basit, Sulman,Khalid, Ahmad Mukhtar,Sabar, Muhammad Farooq,Asad, Sultan,Ali, Agha Shabbir,Mahmoo Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.11
Background and Objectives: Acute lymphoblastic leukemia (ALL) is a complex genetic disease involving many fusion oncogenes (FO) having prognostic significance. The frequency of various FO can vary in different ethnic groups, with important implications for prognosis, drug selection and treatment outcome. Method: We studied fusion oncogenes in 101 pediatric ALL patients using interphase FISH and RT-PCR, and their associations with clinical features and treatment outcome. Results: Five most common fusion genes i.e. BCR-ABL t (22; 9), TCF3-PBX1 (t 1; 19), ETV6-RUNX1 (t 12; 21), MLL-AF4 (t 4; 11) and SIL-TAL1 (del 1p32) were found in 89/101 (88.1%) patients. Frequency of BCR-ABL was 44.5% (45/101). BCR-ABL positive patients had a significantly lower survival ($43.7{\pm}4.24$ weeks) and higher white cell count as compared to others, except patients with MLL-AF4. The highest relapse-free survival was documented with ETV6-RUNX1 (14.2 months) followed closely by those cases in which no gene was detected (13.100). RFS with BCR-ABL, MLL-AF4, TCF3-PBX1 and SIL-TAL1 was less than 10 months (8.0, 3.6, 5.5 and 8.1 months, respectively). Conclusions: This is the first study from Pakistan correlating molecular markers with disease biology and treatment outcome in pediatric ALL. It revealed the highest reported frequency of BCR-ABL FO in pediatric ALL, associated with poor overall survival. Our data indicate an immediate need for incorporation of tyrosine kinase inhibitors in the treatment of BCR-ABL+ pediatric ALL in this population and the development of facilities for stem cell transplantation.
Sabir, Noreen,Iqbal, Zafar,Aleem, Aamer,Awan, Tashfeen,Naeem, Tahir,Asad, Sultan,Tahir, Ammara H,Absar, Muhammad,Hasanato, Rana MW,Basit, Sulman,Chishti, Muhammad Azhar,Ul-Haque, Muhammad Faiyaz,Khali Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.7
Background and objectives: Chromosomal abnormalities play an important role in genesis of acute lymphoblastic leukemia (ALL) and have prognostic implications. Five major risk stratifying fusion genes in ALL are BCR-ABL, MLL-AF4, ETV6-RUNX11, E2A-PBX1 and SIL-TAL1. This work aimed to detect common chromosomal translocations and associated fusion oncogenes in adult ALL patients and study their relationship with clinical features and treatment outcome. Methods: We studied fusion oncogenes in 104 adult ALL patients using RT-PCR and interphase-FISH at diagnosis and their association with clinical characteristics and treatment outcome. Results: Five most common fusion genes i.e. BCR-ABL (t 9; 22), TCF3-PBX1 (t 1; 19), ETV6-RUNX1 (t 12; 21), MLL-AF4 (t 4; 11) and SIL-TAL1 (Del 1p32) were found in 82/104 (79%) patients. TCF3-PBX1 fusion gene was associated with lymphadenopathy, SIL-TAL1 positive patients had frequent organomegaly and usually presented with a platelets count of less than $50{\times}10^9/l$. Survival of patients with fusion gene ETV6-RUNX1 was better when compared to patients harboring other genes. MLL-AF4 and BCR-ABL positivity characterized a subset of adult ALL patients with aggressive clinical behaviour and a poor outcome. Conclusions: This is the first study from Pakistan which investigated the frequency of5 fusion oncogenes in adult ALL patients, and their association with clinical features, treatment response and outcome. Frequencies of some of the oncogenes were different from those reported elsewhere and they appear to be associated with distinct clinical characteristics and treatment outcome. This information will help in the prognostic stratification and risk adapted management of adult ALL patients.